The Ministry of Industry and Information Technology will carry out the action of strengthening the chain of the pharmaceutical industry chain

Zhou Jian, deputy director of the Department of Consumer Goods Industry of the Ministry of Industry and Information Technology, said on the 14th that it will carry out the action of strengthening the chain of the pharmaceutical industry chain, focus on weak links, support upstream and downstream enterprises in the industrial chain to carry out collaborative research, and continue to enhance key core competitiveness
.
Zhou Jian made the above statement at the press conference on the theme of "Promoting the Industrial Variety of Consumer Goods, Improving Quality, and Creating Brands" held by the Ministry of Industry and Information Technology on the
14th.
He said that since the Eighteenth National Congress of the Communist Party of China, the development foundation of China's pharmaceutical industry has become more solid, the driving force has become stronger, and new breakthroughs
have been made in industrial innovation.
"We have established a 'monitoring and early warning platform for the production and supply of drugs in short supply' to improve the ability
to guarantee the supply of drugs.
" Zhou Jian said that the Ministry of Industry and Information Technology organized upstream and downstream enterprises to set up a drug supply guarantee consortium, and together with relevant departments, identified 6 consortiums as centralized production bases for small varieties of drugs (shortage drugs), ensuring the stable production and supply
of 100 small varieties of drugs.
The data released at the meeting showed that in 2021, the added value of China's pharmaceutical industry accounted for 4.
1% of all industries, achieving operating income of 3.
4 trillion yuan, and operating income increased by 80.
8%
compared with 2012.
According to Tianyancha data, as of now, there are more than 40,000 pharmaceutical industry-related enterprises in
China.
"In view of the recent multi-point sporadic situation of the domestic epidemic, we have strengthened the production and scheduling of key medical supplies such as new coronavirus detection reagents and
protective supplies.
Up to now, the weekly production capacity of key antigen testing enterprises has exceeded 500 million parts, the weekly production capacity of nucleic acid testing key production enterprises has exceeded 200 million people, and the annual production capacity of new coronavirus vaccines has exceeded 7 billion doses and the output has exceeded 5.
5 billion doses, which can meet the needs of
the current epidemic prevention and control situation.
He Yaqiong, director of the Department of Consumer Goods Industry of the Ministry of Industry and Information Technology, said
.
Zhou Jian said that the Ministry of Industry and Information Technology will strengthen collaboration with relevant departments to accelerate the industrialization of innovative achievements in the pharmaceutical field, and at the same time, carry out the action of strengthening the chain of the pharmaceutical industry chain, build a number of high-standard APIs centralized production bases, deepen industrial international cooperation, and attract global pharmaceutical innovation elements to gather domestically
.
Pharmaceutical enterprise standards